Skip to main content
ArticleOPEN ACCESS

Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies

Emerging Infectious Diseases
DOI: 10.3201/eid2808.211787
18Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

References Powered by Scopus

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

BMJ (Online)
18764Citations
N/AReaders
Get full text

Rayyan-a web and mobile app for systematic reviews

Systematic Reviews
12280Citations
N/AReaders
Get full text

ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions

BMJ (Online)
11632Citations
N/AReaders
Get full text
View more at Scopus

Cited by Powered by Scopus

A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus

Proceedings of the National Academy of Sciences of the United States of America
15Citations
N/AReaders
Get full text

Inhibition of tick-borne encephalitis virus in cell cultures by ribavirin

Frontiers in Microbiology
6Citations
N/AReaders
Get full text

Lassa fever research priorities: towards effective medical countermeasures by the end of the decade

The Lancet Infectious Diseases
5Citations
N/AReaders
Get full text
View more at Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Cheng, H. Y., French, C. E., Salam, A. P., Dawson, S., McAleenan, A., McGuinness, L. A., … Sterne, J. A. C. (2022, August 1). Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies. Emerging Infectious Diseases. Centers for Disease Control and Prevention (CDC). https://doi.org/10.3201/eid2808.211787

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

55%

Researcher 4

36%

Lecturer / Post doc 1

9%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

44%

Biochemistry, Genetics and Molecular Bi... 2

22%

Nursing and Health Professions 2

22%

Immunology and Microbiology 1

11%

Save time finding and organizing research with Mendeley

Sign up for free